Recombinant human pro-urokinase was non-inferior to alteplase in achieving an excellent functional outcome in patients with acute ischemic stroke but had a lower ICH rate.
Medscape Medical News
Pro-urokinase a Less Expensive Thrombolytic for Stroke
